FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Fenofibric Acid Delayed-Release Capsules
Status: Discontinuation
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Mylan Pharmaceuticals Inc. (New 05/02/2019)

Company Contact Information:
800-796-9526

Presentation Posting Date Related Information
45 mg, 90 count bottle (NDC 0378-2589-77) 05/02/2019
135 mg, 90 count bottle (NDC 0378-2590-77) 05/02/2019

Par Pharmaceutical (New 04/15/2019)

Company Contact Information:
800-828-9393

Presentation Posting Date Related Information
Fenofibric Acid Delayed-Release Capsules 45mg 90s (NDC 10370-209-09) 04/15/2019 Par has made a business decision to permanently discontinue the drug product.
Fenofibric Acid Delayed-Release Capsules 135mg 90s (NDC 10370-210-09) 04/15/2019 Par has made a business decision to permanently discontinue the drug product.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English